Devilee P - Search Results

1

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

Lakeman IMM, van den Broek AJ, Vos JAM, Barnes DR, Adlard J, Andrulis IL, Arason A, Arnold N, Arun BK, Balmaña J, Barrowdale D, Benitez J, Borg A, Caldés T, Caligo MA, Chung WK, Claes KBM; GEMO Study Collaborators; EMBRACE Collaborators; Collée JM, Couch FJ, Daly MB, Dennis J, Dhawan M, Domchek SM, Eeles R, Engel C, Evans DG, Feliubadaló L, Foretova L, Friedman E, Frost D, Ganz PA, Garber J, Gayther SA, Gerdes AM, Godwin AK, Goldgar DE, Hahnen E, Hake CR, Hamann U, Hogervorst FBL, Hooning MJ, Hopper JL, Hulick PJ, Imyanitov EN; OCGN Investigators; HEBON Investigators; KconFab Investigators; Isaacs C, Izatt L, Jakubowska A, James PA, Janavicius R, Jensen UB, Jiao Y, John EM, Joseph V, Karlan BY, Kets CM, Konstantopoulou I, Kwong A, Legrand C, Leslie G, Lesueur F, Loud JT, Lubiński J, Manoukian S, McGuffog L, Miller A, Gomes DM, Montagna M, Mouret-Fourme E, Nathanson KL, Neuhausen SL, Nevanlinna H, Yie JNY, Olah E, Olopade OI, Park SK, Parsons MT, Peterlongo P, Piedmonte M, Radice P, Rantala J, Rennert G, Risch HA, Schmutzler RK, Sharma P, Simard J, Singer CF, Stadler Z, Stoppa-Lyonnet D, Sutter C, Tan YY, Teixeira MR, Teo SH, Teulé A, Thomassen M, Thull DL, Tischkowitz M, Toland AE… See abstract for full author list ➔ Lakeman IMM, et al. Among authors: devilee p. Genet Med. 2021 Sep;23(9):1726-1737. doi: 10.1038/s41436-021-01198-7. Epub 2021 Jun 10. Genet Med. 2021. PMID: 34113011 Free PMC article.

2

Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium.

Narod S, Ford D, Devilee P, Barkardottir RB, Eyfjord J, Lenoir G, Serova O, Easton D, Goldgar D. Narod S, et al. Among authors: devilee p. Am J Hum Genet. 1995 Oct;57(4):957-8. Am J Hum Genet. 1995. PMID: 7573057 Free PMC article. No abstract available.

3

Breast cancer information on the web.

Friend S, Borresen AL, Brody L, Casey G, Devilee P, Gayther S, Goldgar D, Murphy P, Weber BL, Wiseman R. Friend S, et al. Among authors: devilee p. Nat Genet. 1995 Nov;11(3):238-9. doi: 10.1038/ng1195-238. Nat Genet. 1995. PMID: 7581445 No abstract available.

4

An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BA, Weber BL, Garber JE, Birch JM, et al. Narod SA, et al. Among authors: devilee p. Am J Hum Genet. 1995 Jan;56(1):254-64. Am J Hum Genet. 1995. PMID: 7825586 Free PMC article.

5

[Cloning of the first gene for breast/ovarian cancer (BRCA1), mapping of a second gene locus (BRCA2) and consequences for clinical practice].

Oosterwijk JC, Devilee P, Meijers-Heijboer EJ, Menko FH, Klijn JG, Cornelisse CJ. Oosterwijk JC, et al. Among authors: devilee p. Ned Tijdschr Geneeskd. 1995 Mar 4;139(9):421-3. Ned Tijdschr Geneeskd. 1995. PMID: 7891762 Dutch. No abstract available.

6

Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.

Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, King MC, Egilsson V, Devilee P, McManus R, et al. Stratton MR, et al. Among authors: devilee p. Nat Genet. 1994 May;7(1):103-7. doi: 10.1038/ng0594-103. Nat Genet. 1994. PMID: 8075631

7

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.

Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, Cannon-Albright L, Larsson C, Goldgar DE, Narod SA. Phelan CM, et al. Among authors: devilee p. Nat Genet. 1996 Mar;12(3):309-11. doi: 10.1038/ng0396-309. Nat Genet. 1996. PMID: 8589723

8

First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas).

Oosterwijk JC, Jansen JC, van Schothorst EM, Oosterhof AW, Devilee P, Bakker E, Zoeteweij MW, van der Mey AG. Oosterwijk JC, et al. Among authors: devilee p. J Med Genet. 1996 May;33(5):379-83. doi: 10.1136/jmg.33.5.379. J Med Genet. 1996. PMID: 8733047 Free PMC article.

9

The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.

Peelen T, Cornelis RS, van Vliet M, Petrij-Bosch A, Cleton-Jansen AM, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, Devilee P. Peelen T, et al. Among authors: devilee p. Eur J Hum Genet. 1996;4(4):225-30. doi: 10.1159/000472203. Eur J Hum Genet. 1996. PMID: 8875189

10

Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.

Devilee P, Hermans J, Eyfjörd J, Bøorresen AL, Lidereau R, Sobol H, Borg A, Cleton-Jansen AM, Oláh E, Cohen BB, Scherneck S, Hamann U, Peterlin B, Caligo M, Bignon YJ, Maugard C. Devilee P, et al. Genes Chromosomes Cancer. 1997 Mar;18(3):193-9. Genes Chromosomes Cancer. 1997. PMID: 9071572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters